Affect Therapeutics

Affect Therapeutics is a health care startup that provides digital treatment for alcohol and drug addiction through a revolutionary smartphone app. Utilizing contingency management and rewards systems, the app leverages behavioral engineering and gamification principles to stimulate the brain's rewards center, helping individuals reduce their substance use and manage addiction. Accredited by CARF International and supported by NIDA and NIH, Affect's program and technology achieve outcomes more than double of traditional rehab models. The company received a $16.00M Series A investment on July 12, 2023, with investors including City Light Capital, AlleyCorp, Samsung NEXT, LifeArc, Whatif Ventures, and Artis Ventures (AV). Affect Therapeutics aims to make its program accessible to communities without clinics and offers partnership opportunities for organizations addressing the addiction crisis. The company's innovative approach to addiction treatment and strong investor support positions it as an influential player in the healthcare industry.